Delivery Order SPE2DB24D1104-SPE2DB24FYCM6
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Skyrizi 150 mg/ml pens. The contract is a Firm Fixed Price (FFP) instrument with a ceiling value of $21,754.77 and has an ultimate completion date of July 22, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,778.82 firm fixed-price delivery order is for the drug Skyrizi 150 mg/ml pen injector, with a completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide SKYRIZI 150 MG/ML PENML, a medication. The award has a ceiling value of $24,039.78 and a completion date of June 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $44,673.02 and an ultimate completion date of June 6, 2025. It is for the delivery of SKYRIZI 150 MG/ML PENML, a pharmaceutical product. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the specialty medication Skyrizi 150 mg/mL pen injectors. The contract has a ceiling value of $23,479.92 and a completion date of August 6, 2024. This is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML syringes. The contract has a ceiling value of $24,247.82 and a period of performance through August 13, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which serves as the primary vehicle for delivering a comprehensive...
This federal contract award is for the delivery of Skyrizi 150 mg/ml pen injectors, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,468.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2022. This delivery order is part of a larger $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Skyrizi (risankizumab) 150 mg/mL pen injectors. The $18,453.86 firm-fixed-price contract has an ultimate completion date of October 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $19,471.66, is for the supply of the medication Skyrizi (150 mg/mL pen). The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The delivery order has a ceiling value of $23,655.02 and a completion date of October 18, 2024. The contract is a Firm Fixed Price type, and no set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...